These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 3689439

  • 1. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4119-24. PubMed ID: 3689439
    [Abstract] [Full Text] [Related]

  • 2. Characterization of M1- and M2-muscarinic receptors in calf retina membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Vision Res; 1988 Dec 01; 28(2):247-50. PubMed ID: 3414010
    [Abstract] [Full Text] [Related]

  • 3. Identification of M2 muscarinic receptors in membranes from bovine cerebral basal arteries.
    Vanderheyden P, Ebinger G, De Backer JP, Vauquelin G.
    Life Sci; 1986 Oct 27; 39(17):1517-23. PubMed ID: 3762314
    [Abstract] [Full Text] [Related]

  • 4. Selective masking of M1-receptors in calf retina membranes by the venom of the marine snail Conus tessulatus.
    Czerwiec E, de Backer JP, de Potter W, Vauquelin G.
    Neurochem Int; 1993 Jul 27; 23(1):79-85. PubMed ID: 8369735
    [Abstract] [Full Text] [Related]

  • 5. Molecular distinction between calf heart and brain muscarine receptors: different N-ethylmaleimide modulation of agonist binding.
    Vanderheyden P, Kanarek L, Vauquelin G.
    Eur J Pharmacol; 1986 Jun 05; 125(1):127-34. PubMed ID: 3732387
    [Abstract] [Full Text] [Related]

  • 6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 05; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 7. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
    Vanderheyden P, Ebinger G, Dierckx R, Vauquelin G.
    J Neurol Sci; 1987 Dec 05; 82(1-3):257-69. PubMed ID: 3440867
    [Abstract] [Full Text] [Related]

  • 8. Dual effect of N-ethylmaleimide on agonist binding to bovine heart muscarinic receptors.
    Vauquelin G, Vanderheyden P, Ebinger G.
    Arch Int Pharmacodyn Ther; 1990 Dec 05; 307():5-10. PubMed ID: 2095714
    [Abstract] [Full Text] [Related]

  • 9. Selectivity of oxomemazine for the M1 muscarinic receptors.
    Lee SW, Woo CW, Kim JG.
    Arch Pharm Res; 1994 Dec 05; 17(6):443-51. PubMed ID: 10319156
    [Abstract] [Full Text] [Related]

  • 10. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May 05; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 11. Characterization of cholinergic muscarinic receptors in the rabbit iris.
    Honkanen RE, Abdel-Latif AA.
    Biochem Pharmacol; 1988 Jul 01; 37(13):2575-83. PubMed ID: 3291881
    [Abstract] [Full Text] [Related]

  • 12. High-affinity [3H]pirenzepine binding to putative M1 muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15).
    Akiyama K, Watson M, Roeske WR, Yamamura HI.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):289-97. PubMed ID: 6546688
    [Abstract] [Full Text] [Related]

  • 13. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 29; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 14. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    Zhang LB, Horowitz B, Buxton IL.
    Mol Pharmacol; 1991 Dec 29; 40(6):943-51. PubMed ID: 1758444
    [Abstract] [Full Text] [Related]

  • 15. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 29; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 16. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 29; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 17. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul 29; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

  • 18. Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists.
    Vanderheyden P, Gies JP, Ebinger G, De Keyser J, Landry Y, Vauquelin G.
    J Neurol Sci; 1990 Jun 29; 97(1):67-80. PubMed ID: 2370560
    [Abstract] [Full Text] [Related]

  • 19. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
    Wang JX, Roeske WR, Gulya K, Wang W, Yamamura HI.
    Life Sci; 1987 Oct 05; 41(14):1751-60. PubMed ID: 3657382
    [Abstract] [Full Text] [Related]

  • 20. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W, Wolfe BB.
    Mol Pharmacol; 1989 Nov 05; 36(5):749-57. PubMed ID: 2555673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.